Related Articles
Metastatic renal cell carcinoma regains sensitivity to tyrosine kinase inhibitor after nivolumab treatment: A case report
Guillain‑Barre syndrome induced by pembrolizumab and sunitinib: A case report
A comparative study of nivolumab and axitinib in terms of overall survival, treatment continuation, and cost for patients with metastatic renal cell carcinoma
Pembrolizumab therapy in a patient with NSCLC and bullous pemphigoid: A case report
The impact of primary region resection on the therapeutic outcome of combination regimens for metastatic renal cell carcinoma